NAPPI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 194
EU - Europa 96
AS - Asia 67
AF - Africa 10
SA - Sud America 1
Totale 368
Nazione #
US - Stati Uniti d'America 194
IT - Italia 54
SG - Singapore 26
CN - Cina 24
NL - Olanda 18
VN - Vietnam 12
IE - Irlanda 11
CI - Costa d'Avorio 10
SE - Svezia 4
FI - Finlandia 3
FR - Francia 3
JP - Giappone 3
DE - Germania 2
IN - India 2
CL - Cile 1
GB - Regno Unito 1
Totale 368
Città #
Chandler 42
Singapore 20
Amsterdam 18
Ashburn 13
Dong Ket 12
Millbury 12
Beijing 11
Seattle 10
Des Moines 8
Napoli 7
Princeton 6
Nanjing 5
Lawrence 4
Santa Clara 4
Boston 3
Dublin 3
Luzzano 3
Naples 3
Genova 2
Gesualdo 2
Hebei 2
Jiaxing 2
Marcianise 2
Nanchang 2
Norwalk 2
Redwood City 2
Tokyo 2
Campagna 1
Como 1
Dallas 1
Fuzhou 1
Giugliano In Campania 1
Hanover 1
Helsinki 1
Indiana 1
Kunming 1
Milan 1
Nocera Inferiore 1
Otterbäcken 1
Richland 1
Rome 1
Santa Maria Capua Vetere 1
Torre Annunziata 1
Trento 1
Wilmington 1
Totale 220
Nome #
Secondary syphilis mimicking malignancy: A case report and review of literature 54
Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: A real-life experience 49
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 45
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support 42
A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide 39
Safety and comfort of domestic bortezomib injection in real-life experience 39
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 35
Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma 33
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis 30
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report 29
Totale 395
Categoria #
all - tutte 1.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 0 0 1 1 1 0 1 11 8 1
2020/202132 5 0 1 0 7 2 0 2 0 1 0 14
2021/202278 0 0 0 0 0 4 2 1 8 8 31 24
2022/2023100 10 6 5 3 15 9 0 11 15 18 6 2
2023/202458 0 11 2 1 4 6 1 20 1 0 11 1
2024/202528 7 4 0 2 15 0 0 0 0 0 0 0
Totale 395